David R. Ebsworth, Director at Verona Pharma plc (VRNA), bought 36,000 shares at $2.87 ($103K) on 2024-08-12, disclosed to the SEC on 2024-08-14.
Open-market purchase of $103k VRNA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| VRNA | BUY | 2024-11-07 | $189K | — | Filing → |
| VRNA | BUY | 2023-11-08 | $317K | — | Filing → |
| VRNA | SELL | 2021-05-05 | $9K | — | Filing → |